. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers. JAMA Neurol. 2014 Jul 1;71(7):855-62. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
Aβ42
(CSF)
AD
(547)
490 ± 176
pg/mL
ELISA;
Innotest;
Innogenetics
McKhann et al., 1984
Aβ42
(CSF)
CTRL-
Other Controls
(337)
893 ± 232
pg/mL
ELISA;
Innotest;
Innogenetics
tau-phospho
(CSF)
AD
(547)
89 ± 40
pg/mL
ELISA;
Innotest;
Innogenetics
McKhann et al., 1984
tau-phospho
(CSF)
CTRL-
Other Controls
(337)
47 ± 22
pg/mL
ELISA;
Innotest;
Innogenetics
tau-total
(CSF)
AD
(547)
692 ± 404
pg/mL
ELISA;
Innotest;
Innogenetics
McKhann et al., 1984
tau-total
(CSF)
CTRL-
Other Controls
(337)
267 ± 175
pg/mL
ELISA;
Innotest;
Innogenetics

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.